School of Medicine


Showing 1-50 of 90 Results

  • Rodney U. Anderson, MD FACS

    Rodney U. Anderson, MD FACS

    Professor (Clinical) of Urology, Emeritus

    Current Research and Scholarly InterestsClinical Medical Research devoted to tertiary level application of treatment modalities for neurologic and functional disturbances of the genitourinary tract. Problems such as urinary incontinence, urinary retention, urinary flow dysfunction (BPH), impotence, and chronic pelvic pain syndromes are addressed. New medical devices and technology for treating these disorders are investigated

  • Philip Beachy

    Philip Beachy

    The Ernest and Amelia Gallo Professor, Professor of Urology, of Developmental Biology and, by courtesy, of Chemical and Systems Biology

    Current Research and Scholarly InterestsFunction of Hedgehog proteins and other extracellular signals in morphogenesis (pattern formation), in injury repair and regeneration (pattern maintenance). We study how the distribution of such signals is regulated in tissues, how cells perceive and respond to distinct concentrations of signals, and how such signaling pathways arose in evolution. We also study the normal roles of such signals in stem-cell physiology and their abnormal roles in the formation and expansion of cancer stem cells.

  • James D. Brooks

    James D. Brooks

    Keith and Jan Hurlbut Professor

    Current Research and Scholarly InterestsWe use genomic approaches to identify disease biomarkers. We are most interested in translating biomarkers into clinical practice in urological diseases with a particular focus in cancer.

  • Timothy C. Chang

    Timothy C. Chang

    Clinical Assistant Professor, Urology

    BioDr. Timothy Chang is a Clinical Assistant Professor of Urology at Stanford University. He graduated with High Honors from Princeton University and received a Master of Science from Massachusetts Institute of Technology. He then obtained his medical degree and urology residency training from Stanford University School of Medicine. Dr. Chang has experience in a broad range of adult general urologic care, with a particular focus on kidney stone treatment for which he completed specialized fellowship training at Stanford. He received multiple research awards and authored or co-authored numerous academic publications. With his experience in both the engineering and medical fields, he has particular interest in developing technological medical advancements.

  • Bertha Chen, MD

    Bertha Chen, MD

    Professor of Obstetrics and Gynecology (Gynecology - Urogynecology) and, by courtesy, of Urology

    Current Research and Scholarly InterestsDr. Chen’s research examines the molecular causes of urinary incontinence and pelvic floor dysfunction. Recognizing that urinary incontinence linked to demise of smooth muscle sphincter function, she is investigating the potential use of stem cell regeneration to restore muscle capacity.

  • Tony Chen, MD

    Tony Chen, MD

    Clinical Assistant Professor, Urology

    BioDr. Chen is a fellowship-trained urologist who specializes in male reproductive medicine. He is a clinical assistant professor in the Department of Urology at Stanford University School of Medicine.

    Dr. Chen diagnoses and treats male infertility, erectile dysfunction, Peyronie’s Disease, Benign Prostatic Hyperplasia (BPH), hypogonadism, and other disorders of the male genitourinary tract. He emphasizes getting to know the whole patient and utilizing a stepwise approach to treatment when appropriate. When surgery is required, he excels at scrotal surgery, minimally invasive prostate de-obstruction, penile implant placement, microsurgical vasectomy reversal, varicocele treatment, and surgical sperm retrieval.

    For every patient, Dr. Chen develops a personalized care plan emphasizing innovation, safety, and compassion.

    Dr. Chen has published his research findings in journals including Urology Practice, the Journal of Sexual Medicine, Endocrine, the Journal of Pediatric Urology, Journal of Endourology, and elsewhere. Topics have included the association between mortality and male infertility, the association of the COVID-19 pandemic on male sexual function, national trends in vasectomy, and more. He co-wrote the chapter “Simulation and Ureteroscopy” for the textbook Ureteroscopy.

    Dr. Chen is also an innovator with an interest in bringing novel technologies to the field of benign Urology. He has a background in the use of simulation science in medical teaching as well as in prototype design. He has received grant funding to prepare robotic surgeons for acute operating room scenarios and holds a provisional patent on a system for automated urine assessment and monitoring in the hospital.


    He has made presentations on male infertility and surgical simulation at meetings of the American Urological Association, American College of Surgeons, and Sexual Medicine Society.

    Dr. Chen has won recognition for his research and clinical achievements. He has received awards from the Western Section of the American Urological Association, American College of Surgeons, Society of Urologic Prosthetic Surgeons, and Sexual Medicine Society of North America.

    He is a member of the American Urological Association, American College of Surgeons, International Society for Sexual Medicine, American Society for Reproductive Medicine, and Western Section of the American Urological Society.

  • Benjamin I. Chung

    Benjamin I. Chung

    Associate Professor of Urology

    Current Research and Scholarly InterestsRenal cell carcinoma and prostate cancer outcomes research and epidemiology.

  • Craig V. Comiter

    Craig V. Comiter

    Professor of Urology and, by courtesy, of Obstetrics and Gynecology

    Current Research and Scholarly InterestsUsing various animal models of bladder outlet obstruction as a representation of human prostatic disease, I am investigating how intervening with pharmacotherapy, neuromodulation, and other novel therapies may help to reverse the adverse changes in the bladder due to the obstruction.

    I also am investigating new, minimally invasive treatments for post-prostatectomy urinary incontinence.

    I am also investigating the role of neruomodulation in the treatment of chronic pelvic pain and IC.

  • Christos E. Constantinou

    Christos E. Constantinou

    Associate Professor of Urology, Emeritus

    Current Research and Scholarly InterestsMy main recent interest is the application of Biomedical Engineering approaches for the clinical visualization and characterization of the static and dynamic properties of pelvic floor function. This extends to ultrasound Imaging and image processing, construction of computer models and biomechanics analysis of pelvic floor function. It is envisioned that these considerations are important constituents of the clinical evaluation of patients with lower urinary tract dysfunction and urodynamics.

  • Simon Conti

    Simon Conti

    Clinical Associate Professor, Urology

    BioI am a founding member of the Stanford Urolithiasis Project, where we have studied population health datasets to examine surgical outcomes and environmental risk factors in urinary stone disease. Our current focus includes socioeconomic and ethnic disparities in kidney stone disease, water quality and stone disease, pregnancy in kidney stone disease and geographical variations in kidney stones incidence and metabolic kidney stone work up.

  • Amy D. Dobberfuhl, MD, MS

    Amy D. Dobberfuhl, MD, MS

    Assistant Professor of Urology

    Current Research and Scholarly InterestsDr. Dobberfuhl's current clinical practice includes: Pelvic Reconstruction, Neurourology, and Voiding Dysfunction.

  • Christopher Stephen Elliott

    Christopher Stephen Elliott

    Clinical Associate Professor (Affiliated), Urology - Divisions

    BioDr Elliott is a fellowship trained, pelvic reconstructive surgeon with expertise in neurourology. He participated in the physician-scientist program at Ohio State University, receiving both and MD as well as a PhD in epidemiology. After completing his urologic residency at Stanford University Medical Center in 2010, he became Stanford's first Female Pelvic Medicine and Reconstructive Surgery Fellow - a unique two year ABU/ABOG accredited fellowship with both Stanford Urology and Urogynecology faculty training. During this time he received a full experience in pelvic medicine that encompassed both male and female patients. He has clinical and surgical expertise in the management of female pelvic organ prolapse, complex urogynecologic anomalies, overactive bladder, BPH, voiding dysfunction secondary to neurologic disease and both male and female incontinence.
    Starting in 2012, Dr Elliott joined the Division of Urology at Santa Clara Valley Medical Center in San Jose, California with a joint appointment at Stanford University Medical Center. In addition to his clinical work, he has authored several book chapters, published multiple journal articles and taught courses at national meetings (AUA, AUGS). His main academic interests include the epidemiologic study of pelvic organ prolapse, incontinence and bladder dysfunction after spinal cord injury. Dr Elliott is currently a member of the SUFU young members committee and the Neurogenic Bladder Research Group.

    Recent Publications

    1)Spradling K, Sohlberg EM, Li S, Zhang CA, Brubaker WD, Dallas K, Pao AC, Liao J, Leppert JT, Elliott CS, Chung BI, Min GE, Conti SL. Urinary Stone Disease in Pregnancy: Current Management Practices in a Large National Cohort. Urology. 2020 (Epub ahead of print)
    2)Dallas K, Rogo-Gupta L, Syan R, Enemchukwu E, Elliott CS. Balancing the possibility of needing a future incontinence procedure versus a future urethral sling revision surgery: a tradeoff analysis for continent women undergoing pelvic organ prolapse surgery. Int Urogynecol J. 2020 (Epub ahead of print)
    3)Ehsanian R, Creasey G, Elliott CS, Abu-Eid CA, Ali A, Prutton M, Singh H. Implantation of Sacral Nerve Stimulator Without Rhizotomy for Neurogenic Bladder in Patient With Spinal Cord Injury: 2-Dimensional Operative Video. Oper Neurosurg (Hagerstown). 2020 Jan 24. [Epub ahead of print]
    4)Sohlberg EM, Brubaker WD, Zhang CA, Anderegg LDL, Dallas K, Song S, Ganesan C, Chertow G, Pao A, Liao J, Leppert JT, Elliott CS, Conti SL. Urinary Stone Disease in Pregnancy: A Claims-Based Analysis of 1.4 Million Patients. J Urol. 2019 (epub ahead of print)
    5)Song S, Thomas IC, Ganesan C, Sohlberg EM, Chertow GM, Liao JC, Conti S, Elliott CS, Pao AC, Leppert JT. Twenty-Four Hour Urine Testing and Prescriptions for Urinary Stone Disease-Related Medications in Veterans. Clin J Am Soc Nephrol. 2019 (epub ahead of print)
    6)Cheng RZ, Shkolyar E, Chang TC, Spradling K, Ganesan C, Song S, Pao AC, Leppert JT, Elliott CS, To'o K, Conti SL. Ultra-low-dose CT: An Effective Follow-up Imaging Modality for Ureterolithiasis. J Endourol. 2019 (epub ahead of print)
    7)Kasman A, Stave C, Elliott C. Combination therapy in overactive bladder-untapped research opportunities: A systematic review of the literature. Neurourol Urodyn. (2019) epub ahead of print

  • Ekene Enemchukwu, MD, MPH, FACS, FPMRS

    Ekene Enemchukwu, MD, MPH, FACS, FPMRS

    Associate Professor of Urology and, by courtesy, of Obstetrics and Gynecology (Urogynecology)

    Current Research and Scholarly InterestsRefractory overactive bladder in elderly and frail patient populations, detrusor underactivity, quality of life, patient outcomes, quality improvement, patient satisfaction, and shared decision making

  • Alice C. Fan

    Alice C. Fan

    Assistant Professor of Medicine (Oncology) and, by courtesy, of Urology

    Current Research and Scholarly InterestsDr. Fan is a physician scientist who studies how turning off oncogenes (cancer genes) can cause tumor regression in preclinical and clinical translational studies. Based on her findings, she has initiated clinical trials studying how targeted therapies affect cancer signals in kidney cancer and low grade lymphoma. In the laboratory, she uses new nanotechnology strategies for tumor diagnosis and treatment to define biomarkers for personalized therapy.

  • Richard E. Fan

    Richard E. Fan

    Clinical Assistant Professor, Urology

    BioRichard E. Fan, Ph.D., is an engineer embedded in the Department of Urology in the Stanford School of Medicine.

    Dr. Fan’s research relates to the development of clinically driven biomedical instrumentation and medical devices. He is interested in translational application of emerging technologies in the medical and surgical spaces, as well as the development of platforms to explore clinical and pre-clinical evaluation. His primary work is currently focused on image guided detection and treatment of prostate cancer, including MR-US fusion, focal therapies, embedded systems and robotics.

  • Wendy Fantl

    Wendy Fantl

    Associate Professor (Research) of Urology
    On Leave from 08/13/2022 To 08/12/2024

    Current Research and Scholarly InterestsDr Fantl’s lab studies two key questions with unmet clinical need related to drug resistance and immunotherapy focusing on ovarian and kidney cancers. The lab applies multi-parametric single-cell proteomic technologies (mass cytometry aka Cytometry by Time-Of-Flight (CyTOF) and multiplex imaging (CO-Detection by indEXing (CODEX)) combined with specialized computational approaches.

  • Manikantam Gaddam

    Manikantam Gaddam

    Research Engineer, Urology - Divisions

    Current Role at StanfordResearch Engineer

  • Harcharan Gill

    Harcharan Gill

    Kathryn Simmons Stamey Professor, Emeritus

    Current Research and Scholarly InterestsBenign Prostatic Hyperplasia- Evaluation and development of new minimally invasive techniques

    Endourology: developing, designing and evaluating new instruments

    Bladder cancer: outcomes of treatment

    BPH: cryotherapy and HIFU

  • Vanessa Gulla

    Vanessa Gulla

    Clinical Assistant Professor, Urology

    BioDr. Gulla is a board-certified urologist with fellowship training in endourology. She is a clinical assistant professor in the Stanford University School of Medicine Department of Urology.

    For each patient, she develops a comprehensive, compassionate care plan customized to individual needs. Her goal is to help each patient achieve the best possible health and quality of life.

    Dr. Gulla performs the complete spectrum of diagnostic and treatment procedures for urological conditions. She treats disorders including benign prostatic hyperplasia (BPH), blood in urine, kidney stones, male and female voiding dysfunction, neurogenic bladder, prostate cancer, and over active bladder.

    She excels at ureteroscopy and cystoscopy (examination of the bladder and urinary tract with a scope), endourology (minimally invasive treatment of kidney stones), laser therapy, ultrasound-guided diagnosis and treatment, urodynamic testing, and other techniques.

    To help advance her field, Dr. Gulla has conducted research. Among the topics she has investigated are voiding cystourethrogram (VCUG) testing in children for bladder and urethral abnormalities and for conditions that can lead to kidney infections.

    She has presented her research findings at the national meeting of the American Urologic Association. She also has published papers in the Journal of the American College of Surgeons and elsewhere.

    She is a member of the American Urologic Association.

  • Susanna Gunamany

    Susanna Gunamany

    Postdoctoral Scholar, Urology

    BioDr. Gunamany received her PhD in Public Health from the Indian Institute of Technology (IIT) Gandhinagar. Before her doctoral studies, she earned a Master of Public Health (MPH) degree from the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), India, and a Bachelor of Science from the University of Kerala.

    Dr. Gunamany's scholarly pursuits revolve around the convergence of health and technology, with a specific emphasis on mobile health (mHealth) and its potential for improving healthcare delivery and access. Broadening her research scope, she is interested in health disparities and inequalities research, focusing on marginalized populations and the intricate interplay of social, economic, and environmental factors influencing health outcomes.

  • Hassan Jahanandish

    Hassan Jahanandish

    Postdoctoral Scholar, Urology

    BioDr. Hassan Jahanandish is a Postdoctoral Fellow at Stanford School of Medicine, where his research focuses on the intersection of multimodal AI and medical imaging with the overarching objective of advancing care paradigms for cancer patients. Before joining Stanford, he completed his PhD in Bioengineering at the University of Texas at Dallas and the University of Texas Southwestern Medical Center (2022). Beyond his research pursuits, Hassan is an Instructor and Team Mentor at Stanford Center for Biodesign, where he helps shape the future of medical innovation and healthcare entrepreneurship. Hassan's scholarly contributions have been published in numerous journals and conferences, and his work in collaboration with Nokia Bell Labs has been awarded a United States patent. Hassan's achievements have been recognized by awards such as the Jonsson Family Graduate Fellowship in Bioengineering, the Doctoral Dissertation Research Award, and being an International RehabWeek paper award finalist (2019).

  • Kathleen Kan

    Kathleen Kan

    Clinical Assistant Professor, Urology

    BioDr. Kathleen Kan is a fellowship-trained pediatric urologist with a clinical practice based at LPCH and additional outreach programs in the South Bay. Her current practice includes general, endoscopic and complex reconstructive procedures and a clinical counseling interest in kidney stone disease and differences in sexual differentiation. She currently serves as the Associate Program Director of the Urology residency program.

    Her current research is focused on understanding why health elementary schoolchildren develop new bladder and bowel problems.

  • John Leppert

    John Leppert

    Professor of Urology and, by courtesy, of Nephrology

    Current Research and Scholarly InterestsOur research aims to improve the global quality of care for patients with Urologic Cancer with a particular focus on kidney cancer. We are investigating novel proteomic platforms and assays to diagnose kidney cancer and predict response to therapy. We are evaluating the comparative effectiveness of various kidney cancer surgeries and their impact on chronic kidney disease and its downstream effects. We are applying epidemiology, bioinformatics, and health services methods to urologic conditions.

  • Jinhui Li

    Jinhui Li

    Postdoctoral Scholar, Urology

    BioDoctorate degree in Epidemiology & Biostatistics at the University of Hong Kong, which was the joint Ph.D. in Environmental Medicine at New York University, with three years of training in cancer and toxicology at Sun Yat-sen University and five years of medical training. Hold excellent presentation and writing skills with a strong publication record. My primary research interests focus on the epidemiology of urologic cancer, specifically kidney cancer, to broaden the understanding of what causes kidney cancer.